Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2002-08-13
2010-12-14
Kolker, Daniel E (Department: 1649)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S007600, C514S016500, C514S013600, C514S008400, C514S008500, C514S008600, C514S009600, C424S093100
Reexamination Certificate
active
07851447
ABSTRACT:
The subject invention pertains to compositions and methods for promoting repair of damaged nerve tissue. The compositions and methods of the subject invention can be employed to restore the continuity of nerve interrupted by disease, traumatic events or surgical procedures. Compositions of the subject invention comprise one or more chondroitin sulfate proteoglycan (CSPG)-degrading enzymes that promote axonal penetration into damaged nerve tissue. The invention also concerns methods for promoting repair of damaged nerve tissue using the present compositions and nerve tissue treated according to such methods. The invention also pertains to kits for nerve repair.
REFERENCES:
patent: 4696816 (1987-09-01), Brown
patent: 4778467 (1988-10-01), Stensaas et al.
patent: 4877029 (1989-10-01), Valentini et al.
patent: 4933185 (1990-06-01), Wheatley et al.
patent: 5173295 (1992-12-01), Wehling
patent: 5231580 (1993-07-01), Cheung et al.
patent: 5292509 (1994-03-01), Hageman
patent: 5716617 (1998-02-01), Khandke et al.
patent: 5756457 (1998-05-01), Wang et al.
patent: 5830468 (1998-11-01), Bini
patent: 5866120 (1999-02-01), Karageozian et al.
patent: 5916557 (1999-06-01), Berlowitz-Tarrant et al.
patent: 5997863 (1999-12-01), Zimmermann et al.
patent: 6033660 (2000-03-01), Mather et al.
patent: 6054569 (2000-04-01), Bennett et al.
patent: 6093563 (2000-07-01), Bennett et al.
patent: 6200564 (2001-03-01), Lamont et al.
patent: 6214978 (2001-04-01), Truog et al.
patent: 6231608 (2001-05-01), Stone
patent: 6235041 (2001-05-01), Cheng et al.
patent: 6267786 (2001-07-01), Stone
patent: 6313265 (2001-11-01), Phillips et al.
patent: 6448076 (2002-09-01), Dennis et al.
patent: 6455309 (2002-09-01), Stone
patent: 2001/0034043 (2001-10-01), Su et al.
patent: 2001/0039459 (2001-11-01), Stone
patent: 2003/0040112 (2003-02-01), Muir
patent: 2003/0068815 (2003-04-01), Stone et al.
patent: 2003/0077258 (2003-04-01), Muir
patent: 2004/0180434 (2004-09-01), Muir
patent: 2006/0025379 (2006-02-01), Hsieh-Wilson et al.
patent: 2007/0015820 (2007-01-01), Kimura et al.
patent: 19530556 (1996-09-01), None
patent: 0 576 294 (1993-12-01), None
patent: 0 613 949 (1994-09-01), None
patent: 0 776 968 (1997-06-01), None
patent: 0 875 253 (1998-11-01), None
patent: WO 91/06303 (1991-05-01), None
patent: WO 91/06573 (1991-05-01), None
patent: WO 01/35977 (2001-05-01), None
patent: WO 01/39795 (2001-06-01), None
patent: WO03/015612 (2003-02-01), None
Lassmann H., Journal of the Neurological Sciences 233: 83-86, Jun. 2005.
Prabhakar et al. Biochemistry Journal 386: 103-112, Feb. 2005.
Yick et al. NeuroReport 11(5):1063-1067, published Apr. 7, 2000.
Chen et al. Neurochemistry International 33: 341-351, Jun. 1998.
Ramon-Cueto 1998 Journal of Neuroscience 18:3803-3815.
Schmalfeldt et al., “Brain Derived Versican V2 is a Potent Inhibitor of Axonal Growth,”Journal of Cell Science113: 807-816 (2000).
Krekoski, C.A. et al. “Metalloproteinase-Dependent Predegeneration In Vitro Enhances Axonal Regeneration within Acellular Peripheral Nerve Grafts”J. Neuroscience, Dec. 2002, 22(23):10408-10415.
Lemons, M.L. et al. “Chondroitin Sulfate Proteoglycan Immunoreactivity Increases Following Spinal Cord Injury and Transplantation”Exper. Neuro., 1999, 160:51-65.
McKeon, R.J. et al. “Reduction of Neurite Outgrowth in a Model of Glial Scarring following CNS Injury is Correlated with the Expression of Inhibitory Molecules on Reactive Astrocytes”J. Neurosci., 1991, 11(11):3398-3411.
McKeon, R.J. et al. “Injury-Induced Proteoglycans Inhibit the Potential for Laminin-Mediated Axon Growth on Astrocytic Scars”Exp. Neuro., 1995, 136:32-43.
Yick, L-W. et al. “Chondroitinase ABC promotes axonal regeneration of Clarke's neurons after spinal cord injury”NeuroReport, 2000, 11(5):1063-1067.
Bradbury, E.J. et al. “Chondroitinase ABC promotes functional recovery after spinal cord injury”Nature, 2002, 416:636-640.
Jones, L.L. et al. “Neurotrophic factors, cellular bridges and gene therapy for spinal cord injury”J. Physiology, 2001, 533.1:83-89.
Smith-Thomas, L.C. et al. “Increased axon regeneration in astrocytes grown in the presence of proteoglycan synthesis inhibitors”J. Cell Sci., 1995, 108:1307-1315.
Smith-Thomas, L.C. et al. “An inhibitor of neurite outgrowth produced by astrocytes”J. Cell Sci., 1994, 107:1687-1695.
Muir, D. et al. “Schwannoma Cell-derived Inhibitor of the Neurite-promoting activity of Laminin”J. Cell Biol., Nov. 1989, 109:2353-2362.
Bennett, G.S. et al. “Chondroltinase ABC delivered to the site of a spinal cord injury upregulates GAP-43 expression in dorsal root ganglion neurons”Society for Neuroscience Abstracts, 2000, 26(1-2):Abstract No. 324.3 from 30thAnnual Meeting of the Society of Neuroscience, presented Nov. 2000; mailed to subscribers Sep. 2000.
Agius, E. and P. Cochard “Comparison of Neurite Outgrowth Induced by Intact and Injured Sciatic Nerves: A Confocal and Functional Analysis”The Journal of Neuroscience, Jan. 1, 1998, 18(1):328-338.
Bertolotto, A. et al. “Immunohistochemical Localizationof Chondroitin Sulfate in Normal and Pathological Human Muscle”J Neurol Sci, 1986, 73:233-244.
Bradbury, E.J. et al. “Chondroitinase ABC Delivered to the Site of a Spinal Cord Injury Upregulates GAP-43 Expression in Dorsal Root Ganglion Neurons”Soc. Neurosci Abstr, Nov. 2000, abstract presented at the 30thAnnual Meeting of the Society of Neuroscience.
Danielsen, N. et al. “Predegeneration enhances regeneration into acellular nerve grafts”Brain Res, 1995, 681:105-108.
Danielsen, N. et al. “Pre-degenerated nerve grafts enhance regeneration by shortening the initial delay period”Brain Res, 1994, 666:250-254.
Evans, P.J. et al. “The Peripheral Nerve Allograft: A Comprehensive Review of Regeneration and Neuroimmunology”Prog Neurobiol, 1994, 43:187-233.
Evans, P.J. et al. “Cold Preserved Nerve Allografts: Changes in Basement Membrane, Viability, Immunogenicity, and Regeneration”Muscle Nerve, Nov. 1998, 21:1507-1522.
Fawcett, J.W. and R.J. Keynes “Peripheral Nerve Regeneration”Annu Rev Neurosci, 1990, 13:43-60.
Ferguson, T.A. and D. Muir “MMP-2 and MMP-9 Increase the Neurite-Promoting Potential of Schwann Cell Basal Laminae and Are Upregulated in Degenerated Nerve”Mol Cell Neurosci, 2000 16:157-167.
Fu, S.Y. and T. Gordon “The Cellular and Molecular Basis of Peripheral Nerve Regeneration”Mol Neurobiol, 1997, 14(1):67-116.
Giannini, C. and P. Dyck “The Fate of Schwann Cell Basement Membranes in Permanently Transected Nerves”J Neuropathol Exp Neurol, 1990, 49(6):550-563.
Gordon, L. et al. “Predegenerated nerve autografts as compared with fresh nerve autografts in freshly cut and precut motor nerve defects in the rat”J Hand Surg [Am], Jan. 1979, 4(1):42-47.
Gulati, A.K. “Evaluation of acellular and cellular nerve grafts in repair of rat peripheral nerve”J Neurosurg, Jan. 1988, 68:117-123.
Ide, C. et al. “Schwann Cell Basal Lamina and Nerve Regeneration”Brain Res, 1983, 288:61-75.
Kherif, S. et al. “Matrix metalloproteinases MMP-2 and MMP-9 in denervated muscle and injured nerve”Neuropathol Appl Neurobiol, 1998, 24:309-319.
Krekoski, C.A. et al. “Axonal Regeneration into Acellular Nerve Grafts Is Enhanced by Degradation of Chondroitin Sulfate Proteoglycan”The Journal of Neuroscience, Aug. 15, 2001, 21(16):6206-6213.
La Fleur, M. et al. “Basement Membrane and Repair of Injury to Peripheral Nerve: Defining a Potential Role for Macrophages, Matrix Metalloproteinases, and Tissue Inhibitor of Metalloproteinases-1”J. Exp. Med., Dec. 1996, 184:2311-2326.
Langley, J.N. and H.K. Anderson “The Union of Different Kinds of Nerve Fibres”J Physiol, 1904, 31:365-391.
Levi, A. et al. “Cold Storage of Peripheral Nerves: An In Vitro Assay of Cell V
Kolker Daniel E
Saliwanchik Lloyd & Saliwanchik
University of Florida Research Foundation Inc.
LandOfFree
Methods for nerve repair does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for nerve repair, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for nerve repair will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4165874